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iPSC-derived neural precursors exert a
neuroprotective role in immune-mediated
demyelination via the secretion of LIF
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The possibility of generating neural stem/precursor cells (NPCs) from induced pluripotent
stem cells (iPSCs) has opened a new avenue of research that might nurture bench-to-bedside
translation of cell transplantation protocols in central nervous system myelin disorders. Here
we show that mouse iPSC-derived NPCs (miPSC-NPCs)—when intrathecally transplanted
after disease onset—ameliorate clinical and pathological features of experimental auto-
immune encephalomyelitis, an animal model of multiple sclerosis. Transplanted miPSC-NPCs
exert the neuroprotective effect not through cell replacement, but through the secretion of
leukaemia inhibitory factor that promotes survival, differentiation and the remyelination
capacity of both endogenous oligodendrocyte precursors and mature oligodendrocytes. The
early preservation of tissue integrity limits blood–brain barrier damage and central nervous
system infiltration of blood-borne encephalitogenic leukocytes, ultimately responsible for
demyelination and axonal damage. While proposing a novel mechanism of action,
our results further expand the therapeutic potential of NPCs derived from iPSCs in myelin
disorders.
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T
he development of cell-based therapies aimed at promoting
remyelination in patients suffering from myelin disorders
has been pursued in the last 30 years1,2. Although
successful in supporting site-specific repair in focal myelin
disease3, most of these cell-based therapeutic approaches have
been mostly unsuccessful in multifocal inflammatory
demyelinating diseases of the central nervous system (CNS),
such as multiple sclerosis (MS).
The recent demonstration that neural stem/precursor cell
(NPCs)-based therapies can promote neuroprotection in experi-
mental models of MS not only via cell replacement but also by
secreting neuroprotective molecules—the so called bystander
effect4–7— has suggested that such cells might represent in the
near future a plausible alternative cell source for cell-based
therapeutic strategy in MS. However, bench-to-bedside transla-
tion of NPC-based therapies in MS is still hampered by the
allogenic nature of the so far only available source of NPCs
for human trials. Indeed, although capable of promoting
neuroprotection in a non-human primate model of MS8, fetal-
derived NPCs do require concomitant immunosuppression when
transplanted in humans.
Induced pluripotent stem cells (iPSCs)—a new source of
pluripotent stem cells obtained by genetic reprogramming of
somatic cells9–11— might represent the ideal autologous source
of NPCs for transplantation and translational purposes in MS.
However, although the ability of iPSC-derived myelin-forming
cells (for example, OPCs) to remyelinate congenitally
demyelinated mice has been recently shown3, nothing is known
about the capacity of these cells to protect neural tissue
once transplanted in an hostile inflammatory demyelinated
environment such as that characterizing MS.
Here we show that mouse iPSC-derived NPCs (thereafter
referred as miPSC-NPCs)—when intrathecally transplanted after
disease onset in mice with experimental autoimmune encepha-
lomyelitis (EAE), an animal model of MS—ameliorate clinical
and pathological features of the disease. Transplanted miPSC-
NPCs exert a neuroprotective effect in EAE not by differentiating
into myelin producing cells but via the secretion of a specific
neurotrophin, that is, leukaemia inhibitory factor (LIF), able to
support the in vivo survival and differentiation of resident
oligodendrocytes. This neuroprotective effect is, in turn, sufficient
to limit the CNS-confined inflammatory process and the extent of
the tissue damage.
Results
Generation of miPSCs from Sox2bGeo mouse fibroblasts.
Mouse embryonic fibroblasts (MEFs) were isolated from E14.5
Sox2bGeo knock-in E14.5 C57Bl/6 Sox2bgeo/bgeo knock-in mouse
embryos12 and transduced with a lentiviral vector encoding for the
Oct4, Sox2 and Klf4 transcription factors. miPSCs derived from
the reprogramming of Sox2bGeo MEFs (Fig. 1a) express a bgeo
cassette under the control of Sox2 promoter that gives cell resis-
tance to neomycin and the ability to be recognized by X-gal
staining (Fig. 1b). Five days after transduction, cells were harvested
and plated onto mitomycin C-treated MEF feeder cells. Thirty days
later, some flat and round colonies were observed (Fig. 1a). miPSC
colonies were picked based on morphological criteria and treated
with Neomycin to select for cells reactivating the endogenous Sox2
gene. Undifferentiated miPSCs formed colonies very similar to
murine embryonic stem cells (ESCs) (Fig. 1a), expressing the
endogenous Sox2 gene (Fig. 1b). In vitro, the pluripotent state of
miPSCs was validated by alkaline phosphatase (AP) activity
(Fig. 1c) and by the expression of non-viral ESC marker genes such
as Nanog, Oct4, Sox2, Klf4, SSEA-1 (Fig. 1d–f,j). Moreover, upon
embryoid bodies (EBs) formation, the presence of cells belonging
to the three embryonic layers was confirmed by immunostaining
for bIIITubulin (ectoderm), alpha smooth muscle actin (aSMA)
(mesoderm) and forkhead box protein A2 (Foxa2) (endoderm)
(Fig. 1g–i). In vivo, the generation of chimeric mice after blastocyst
injection (Fig. 1k), and the formation of teratomas upon miPSCs
transplantation into testes of SCID beige mice, provided further
proof of the pluripotency of our miPSCs. Histological examination
of tumours revealed the presence of tissues originating from the
three germinal layers (Fig. 1l–o).
Generation of miPSC-NPCs from Sox2bGeo miPSCs. A stable
population of NPCs was derived from miPSCs Sox2bGeo
(Fig. 2)—thereafter referred as miPSC-NPCs—as previously
described13. Briefly, miPSCs Sox2bGeo, when plated in serum-
free media, generated rosette-like structures, the hallmark of
neuroepithelial differentiation. After 3–4 passages in neural pre-
cursors medium, cells were able to support neural progenitor
proliferation, and additional split allowed us to purify an adher-
ent homogeneous population of NPCs with a typical elongated
bipolar morphology, end feet and oval nuclei (Fig. 2a). Cells were
labelled in vitro using a third generation lentiviral vector
encoding for GFP protein. More than 80% of the cells were
labelled with this method (Fig. 2b). The neural stem cell identity
of miPSC-NPCs was confirmed by the expression of the neural
stem cell markers Nestin, Sox2, Olig2, Vimentin, BLBP, GLAST
and Mash1 (Fig. 2c–h). Accordingly, miPSC-NPCs were able to
self-renew over an extended period of time (Fig. 2i) and gave rise
to neurons, astrocytes and oligodendrocytes when exposed to
differentiating conditions (Fig. 2j–l)14–16. In conclusion, miPSC-
NPCs met all the requirements of bona fide NPCs.
miPSC-NPC treatment promotes functional recovery of EAE
mice. miPSC-NPCs were intrathecally transplanted into mice
suffering from myelin oligodendrocyte glycoprotein (MOG) pep-
tide 35–55-induced EAE at the peak of the disease (17.96±1.53
days post immunization (dpi)). Given the safety concerns related
to the clinical translation of iPSC therapy17, we first analysed both
CNS and peripheral organs from transplanted mice at 3 and
6 months after the cell injection and we did neither observe
any toxicity nor tumour formation associated to miPSC-NPC
treatment (Supplementary Fig. S1). At 40 dpi, miPSC-NPC-treated
EAE mice significantly ameliorated compared with sham- and
MEF-treated mice (Fig. 3a, Supplementary Fig. S2). Moreover, the
inhibitory effect of miPSC-NPCs on EAE was specific and could
not be obtained by other neural cells as there was no difference
between astrocyte-transplanted and sham-treated groups in terms
of clinical severity (Supplementary Fig. S2, Table 1). The ther-
apeutic effect of miPSC-NPCs persisted up to the end of the fol-
low-up: at 80 dpi, miPSC-NPC-treated mice reached an average
EAE score of 1.0 (tail paralysis), while sham-treated mice reached
an average score of 2.0 (hind limb paresis) (Fig. 3a). The clinical
amelioration was paralleled by histopatological evidence of the
reduction of demyelinated areas and axonal damage (Fig. 3b–d).
Differentially expressed genes (DEG) analysis of the transcriptional
profile associated with miPSC-NPC treatment of EAE mice found
428 differentially expressed probes (174 upregulated and 254
downregulated probes versus sham-treated group, Fig. 4a, right
circle and Supplementary Data 1). Interestingly, among the 428
miPSC-NPC-related hits, 184 (B43%) appeared also among the
EAE-related transcripts. Notably, out of 184 probes, 182 (50
upregulated and 132 downregulated) were expressed in miPSC-
NPC spinal cord at levels similar to those measured in the spinal
cord of naive animals (Venn diagram in Fig. 4a). Accordingly,
unsupervised hierarchical clustering based on the 184 common
probes classified the miPSC-NPC group along with the naive
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group (Fig. 4b), providing the molecular evidence that the ther-
apeutic effects exerted by transplanted miPSC-NPCs counter-
balanced the EAE-associated transcriptional changes.
miPSC-NPCs persist undifferentiated within perivascular
infiltrates. To further investigate the mechanism sustaining the
neuroprotective effect of miPSC-NPC transplantation, we then
analysed the tissue distribution of transplanted miPSC-NPCs
in EAE mice. At 40 dpi, 1% of transplanted miPSC-NPCs
localized within the entire neuraxis of EAE mice and distributed
with a concentration gradient from the injection site to the
caudal end of the CNS (Fig. 3e). Transplanted cells were found
almost exclusively around subpial vessels where perivascular
inflammatory infiltrates (Fig. 3f) and myelin damage were visible
(Fig. 3g). The vast majority (79%) of transplanted cells
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Figure 1 | Mouse induced pluripotent stem cells (miPSCs) generation and characterization. (a,b) miPSCs derived from the reprogramming of E14.5
C57Bl/6 Sox2bgeo/bgeo knock-in mouse embryo fibroblasts (miPSCs Sox2bgeo) (a) express a bgeo cassette under the control of Sox2 promoter that gives
cell resistance to neomycin and the ability to be recognized by X-gal staining (b). (c–f) Immunochemistry for AP (c), Oct4 (d), Nanog (e) and SSEA-1
(f). Scale bar, 50mm. (g–i) Immunostaining on differentiated miPSCs Sox2bgeo for bIIITubulin (ectoderm) (g), smooth muscle actin alpha (a-SMA;
mesoderm) (h) and forkhead box protein A2 (FOXA2; endoderm) (i). Scale bar, 50mm. (j) PCR analysis showing the activation of the endogenous
pluripotency related genes: Oct4 endo 224 bp; Sox2 endo 297 bp; and Klf4 endo 711 bp. (k) Blastocyst injection of GFP-positive miPSC Sox2bgeo generates
chimeric mice. Scale bar, 5mm. (l–o) Haematoxylin and Eosin staining on teratoma shows differentiated structures from all three germ layers. Immature
epithelium (ectoderm) (l, arrows), muscle (mesoderm) (m, arrow), cartilage (mesoderm) (n, arrowhead), neural ectoderm (ectoderm) (n, arrow),
glands (endoderm) (o, arrow).Scale bar, 1mm.
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maintained an undifferentiated phenotype (round morphology)
and expressed nestin (Fig. 3f,g,l); only a small fraction displayed
neuronal and glial differentiation markers—for example,
Olig2 (2,2%), GFAP (0,6%), bIIITubulin (0,3%)—and the 6% of
them proliferated (Fig. 3h–l). We attributed the miPSC-NPC
pathotropism toward inflammatory lesions to the constitutive
expression of chemotactic molecules such as CD44, VLA-4 and
CXCR4 (Fig. 2m–o), as previously shown also for adult
NPCs6,7,18–20.
miPSC-NPCs restrain demyelination and promote remyelina-
tion. Despite the lack of differentiation of transplanted cells into
myelin-forming cells, the significant reduction of demyelination
in the spinal cord of miPSC-NPC transplanted mice prompted us
to further analyse the cellular characteristics of damaged areas.
Within the demyelinating lesions of miPSC-NPC-treated EAE
mice, we found an increased number of both proliferating
Ki67þ /Olig2þ OPCs (0.69±0.19 versus 1.48±0.22 cells per
field) (Fig. 5a–c) and mature CC1þ oligodendrocytes
(4132±796.4 versus 2027±241.9 cells mm 2) (Fig. 5d–f). At the
same time, we also found a reduction of apoptotic mature CC1þ /
Caspase3þ oligodendrocytes (Fig. 5g–i) (9.17±3.08 versus
27.21±3.49% of cells).
Furthermore, ultrastructural analysis revealed a better pre-
servation of myelin and axonal integrity (Fig. 5j,k) and a
significant (t-test P¼ 0.04) increase of remyelinated axons in
miPSC-NPC compared with sham-treated EAE mice (Fig. 5l).
These latter results were paralleled by a significant decrease of
demyelinated axons (Fig. 5m) and increase of myelinated axons
(Fig. 5n) in miPSC-NPC compared with sham-treated EAE mice;
a finding not depending from axon diameter (Fig. 5o). Finally,
increased numbers of pro-myelinating PLP-DM20þ OPCs
(313.7±16.79 versus 202.5±15.73 cellsmm 2) (Fig. 5p–r) as
well as increased levels of myelin basic protein (MBP) were found
in the spinal cord tissue of miPSC-NPC versus sham-treated EAE
mice (Fig. 5s,t); thus, further supporting an ongoing process of
remyelination.
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Figure 2 | Neural conversion of miPSC Sox2bgeo. (a) Bright field image of miPSC-NPCs obtained from miPSC Sox2bgeo. Scale bar, 50mm. (b) GFP
expression on miPSC-NPCs upon LV infection. Scale bar, 50mm. (c–h) Immunostaining for Nestin (c), Vimentin (d), Olig2 (e), Mash1 (f), Sox2 (g)
and GLAST (h). Scale bar, 50mm. (i) Growth curve of miPSC-NPC. (j–l) Differentiation of miPSC-NPCs in three neural-derived cell populations, neurons (j),
astrocytes (k) and oligodendrocytes (l). Scale bar, 50mm. (m–o) Expression of the adhesion molecule CD44 (m), the chemokine receptor CXCR4 (n)
and the integrin VLA-4 (o) on in vitro cultured miPSC-NPCs analysed by flow-activated cell sorting (FACS). Grey line represents the isotype control,
whereas red line indicates the stained cells.
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Taken together, these results indicate that miPSC-NPC
treatment preserves not only the viability but also the
functionality of OPCs and mature oligodendrocytes, as these
endogenous cells resulted capable of promoting remyelination
and preservation of axonal integrity.
Inflammation fosters miPSC-NPC-mediated OPC protection
via LIF. Given the propensity to maintain an undifferentiated
phenotype upon in vivo transplantation, we postulated that
miPSC-NPCs exerted the pro survival effect on OPCs and mature
oligodendrocytes by releasing soluble trophic molecules7,21. Thus,
we exposed in vitro OPCs to the medium obtained from miPSC-
NPCs pre conditioned or not in vitro with TNFa and IFNg
(Fig. 6a); these latter two pro-inflammatory cytokines were used
to mimic the inflamed tissue microenvironment in which trans-
planted miPSC-NPCs exerted their therapeutic functions as we
previously showed6. After 5 days in culture, we found a significant
increase of both OPCs and mature oligodendrocytes—as indi-
cated by the increased number of O4þ cells (47.3±6.3% versus
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Figure 3 | Intrathecally transplanted miPSC-NPCs improve disease severity in EAE mice while remaining undifferentiated within perivascular spinal
cord areas. (a) EAE clinical score of miPSC-NPC- (black dots) and sham-treated mice (white dots). Each point represents the mean disease score
of at least 10 mice per group (±s.e.m.); two-way ANOVA; *Po0.05; **Po0.01. (b) Quantification of spinal cord demyelination and axonal damage at
80 dpi in miPSC-NPC- (black bars) versus sham-treated (white bars) EAE mice (N¼6 per group). Data (mean values±s.e.m.) represent the percentage
of damage. Student’s t-test; *Po0.05; **Po0.01. (c,d) Representative images of spinal cord sections stained with Luxol Fast Blue (c) and Bielschowsky
(d). Red dotted lines represent areas of damage. Scale bar, 200mm. (e) Quantitative analysis of the localization of miPSC-NPCs upon transplantation into
EAE mice (N¼ 3). (f–k) Immunostaining for CD45, MBP, Nestin, Ki67, Olig2, GFAP, bIII tubulin and GFP shows accumulation of transplanted cells
(arrowheads) within perivascular spinal cord damaged areas. Dotted lines represent vessels. Nuclei are visualized with DAPI. Scale bars, 50 mm.
(l) Percentage (±s.e.m.) of the miPSC-NPCs expressing the different neural differentiation markers upon transplantation into EAE mice; the majority of
transplanted miPSC-NPCs remained undifferentiated. (N¼ 3 mice per group).
Table 1 | Clinical characteristics of C57BL/6 EAE mice transplanted intrathecally with miPSC-NPCs, murine fibroblasts and
murine astrocytes.
Treatment No. of
mice
EAE
incidence
Disease
onset (dpi)*
Day of
treatment (dpi)*
Clinical score
at treatmentw
No. of dead
mice
Mean clinical
score at 40 dpi
Mean clinical
score at 80 dpi
miPS-NPCs 40 100% 13.73±1.48z 17.73±1.48 2.55±0.27 0 1.62±0.79 1.00±0.70
Sham 40 100% 14.19±1.57 18.19±1.57 2.68±0.37 2 2.30±0.33y 2.00±0.44y
Fibroblasts 7 100% 12.14±0.90 16.14±0.90 2.83±0.52 0 2.33±0.52y ND
Astrocytes 6 100% 12.67±0.81 16.67±0.81 2.64±0.38 0 2.38±0.25y ND
dpi, days post immunization; EAE, experimental autoimmune encephalomyelitis; miPSC-NPCs, mouse iPSC-derived NPCs; ND, not determined.
*Disease onset and day of treatment are expressed as days post immunization (dpi).
wData are means±s.e.
zData have been calculated the day of randomization before starting the treatment.
yPo0.05 versus miPSC-NPC transplanted mice (Mann-Whitney test)..
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Figure 4 | Spinal cord transcriptomics in naive mice and miPSC-NPC- or sham-treated EAE mice. (a) Workflow of transcriptome analysis showing the
differential expression between miPSC-NPC versus sham-treated EAE mice and naive mice versus sham-treated EAE mice. (b) Unsupervised hierarchical
sample clustering based on 184 DEG common to the miPSC-NPC- versus sham-treated EAE mice and naive mice versus sham-treated EAE mice
comparisons. (c) Unsupervised sample clustering based on 428 DEG between miPSC-NPC- and sham-treated EAE mice. (d) Significantly enriched KEGG
pathways within the transcriptional profile from miPSC-NPC versus sham-treated EAE mice. (e) Significantly enriched biological processes in Gene
Ontology. The colour gradient ranging from yellow to orange indicates the increasing statistical significance.
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26.9±4.09%), MBPþ cells (17.1±1.2% versus 5.1±3.1%) and
O4þ /Ki67þ cells (5.3±0.7% versus 0.3±0.2%)—in cultures
treated with the TNFa/IFNg pre conditioned medium compared
to cultures treated with non-conditioned medium (Supplemen-
tary Fig. S3a–e). This finding suggested that miPSC-NPCs, upon
inflammatory stimuli, secrete soluble factors with a trophic effect
on both OPCs and mature oligodendrocytes. We next analysed
which soluble molecule could be responsible for the trophic effect.
Among several trophic factors tested, only the expression of LIF
resulted markedly increased when miPSC-NPCs were challenged
with TNFa/IFNg (Fig. 6b). As a confirmation of LIF causative role,
we found that anti-LIF antibody was able to inhibit OPC pro-
liferation (of 5.3±0.7% versus 2.8±0.9% of O4þ /Ki67þ ) and
differentiation into mature MBPþ oligodendrocytes (17.1±1.2%
versus 5.7±2.1%) as well as to reduce both OPCs and oligoden-
drocyte viability (47.3±6.2% versus 5.3±0.7% of O4þ cells) when
added to the TNFa/IFNg pre conditioned miPSC-NPC media
(Fig. 6c–h). Moreover, the effect on OPCs and oligodendrocytes
exerted by miPSC-NPC medium pre conditioned with TNFa/IFNg
was mimicked by rLIF (Fig. 6c–i). Together these data indicate that
inflammation drives miPSC-NPCs to support OPC and oligoden-
drocyte survival and differentiation through the secretion of LIF.
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LIF exerts a trophic effect on endogenous oligodendrocytes.
We next investigated whether LIF was also responsible of the
in vivo effect observed upon miPSC-NPC transplantation in EAE
mice. We first showed that transplanted miPSC-NPCs located
within perivascular inflammatory infiltrates—and therefore
sensing the inflammatory environment—produce LIF; a
finding confirmed at both protein and mRNA levels via immu-
nofluorescence and in situ hybridization (Fig. 7a,b). Then, we
observed an increased level of the phosphorylated form of the
signal transducer and activator of transcription-3 (pSTAT3), a
well-known downstream LIF pathway signalling molecule22, in
the spinal cord of miPSC-NPC- compared with sham-treated
EAE mice (Fig. 7c,d) and an increased number of CC1þ oligo-
dendrocytes expressing pSTAT3 (Fig. 7e,f). Finally, miPSC-NPC
transplanted EAE mice treated with a continuous intrathecal
infusion of the neutralizing anti-LIF antibody showed a sig-
nificantly more severe EAE (mean score post-treatment 3.2±0.3
versus 2.2±0.2) (Fig. 7g). Interestingly, although the number of
inflammatory infiltrates at 30 dpi was superimposable among
groups (Fig. 7h), a significant increase in the percentage of
demyelinated areas (1.9±0.2% versus 1.15±0.1%) (Fig. 7i),
in the number of apoptotic mature CC1þ /Caspase3þoligo-
dendrocytes (11.29±5.49% versus 32.58±0.48%) (Fig. 7j) as well
as a reduction of mature CC1þ oligodendrocytes (1,086±248.0
versus 4,398±1,860 cellsmm 2) (Fig. 7k) was found in EAE
mice treated with iPSC-NPCs plus anti-LIF ab versus mice treated
with miPSC-NPCs alone. Collectively, these results indicate an
activation of the LIF pathway in vivo upon miPSC-NPC trans-
plantation, and confirm that LIF is necessary for the clinical
amelioration and myelin preservation induced by miPSC-NPC
transplantation.
miPSC-NPC trophic effect limits CNS-confined inflammation.
Oligodendrocyte death occurring as a consequence of EAE results
in the generation of partially disrupted myelin debris that act as
endogenous inflammatory stimuli capable of exacerbating the
CNS-confined inflammatory process23. As a direct consequence
of this phenomenon axonal regeneration and remyelination are
inhibited24 and BBB permeability altered25. Transcriptomics and
functional annotation data—indicating that transcripts involved
in cell survival/death processes were differentially regulated in
miPSC-NPC transplanted EAE mice at 40 dpi (Fig. 4d,e and
Supplementary Data 1)—and the observed reduction of apoptotic
mature oligodendrocytes in transplanted mice (Fig. 5g–i)
prompted us to evaluate whether or not the neuroprotective effect
exerted by miPSC-NPCs might have also indirectly affected the
overall neuroinflammatory reaction. We first analysed the
inflammatory burden in miPSC-NPC and sham-treated mice at
different time points after EAE onset. At 30 dpi, we found that the
number and the composition of the CNS inflammatory
infiltrates—including enchephalitogenic Th1 and Th17 cells—
were similar between the two groups (Figs 8a–o and 9a,c–e).
Moreover, real-time PCR analysing the expression of molecules
usually associated with blood derived beneficial (M2) monocytes/
macrophages26,27—that is, Arginase1, CD206, YM-1, IL4Ra and
TGFb—were similarly expressed in the whole-spinal cord of
sham- versus miPSC-NPC-treated EAE mice (Fig. 8p–t).
At the same time point, demyelination and axonal loss were
significantly reduced in miPSC-NPC-treated EAE mice (Fig. 9b).
Contrariwise, at 40 dpi, inflammation was significantly less
pronounced in miPSC-NPC versus sham-treated EAE mice
(Fig. 9a). At 80 dpi, inflammation subsided in both groups of
EAE mice (Fig. 9a).
As the kinetic of the inflammatory burden in transplanted EAE
mice was compatible with the working hypothesis, we further
assessed which of the inflammatory components was involved in
this process. We focused on BBB not only because an increase of
BBB permeability is a key event leading to CNS infiltration of
blood-borne inflammatory cells28 but also because pathway
analysis revealed an enrichment in sham-treated versus
transplanted EAE mice of transcripts belonging to two BBB-
related pathways, that is, tight-junctions and adherent-junctions,
and one pathway related to CNS migration of inflammatory
blood-borne mononuclear cells, that is, leukocyte transendothelial
migration (Fig. 4d). Quantitative RT–PCR analysis confirmed a
return to baseline values of mRNA levels of vascular cell adhesion
protein 1 (VCAM1), platelet/endothelial cell adhesion molecule 1
(PECAM1), intercellular adhesion molecule 1 (ICAM1) and
integrin (alpha L) lymphocyte function-associated antigen 1
(ITGAL1), Chaderin-5 upon miPSC-NPC transplantation in EAE
mice (Fig. 9f–j). On the other hand, expression level of ZO-1—a
molecule necessary to seal the BBB and reduce permeability and
cellular extravasation29—was increased upon miPSC-NPC
treatment compared with the baseline level (Fig. 9k–m). As all
these findings indicated that miPSC-NPC transplantation might
have preserved BBB integrity, we next assessed BBB permeability.
A significant reduction of IgG extravasation was observed in
miPSC-NPC versus sham-treated EAE mice as early as 30 dpi
(Fig. 9n,o); a reduction which was further increased at 40 dpi
Figure 5 | miPSC-NPC transplantation restrains myelin damage and promote remyelination in EAE mice. (a–c) Quantification of Olig2þ/Ki67þ OPCs
in the posterior column of the spinal cord from sham- (white bar) versus miPSC-NPC- (black bar) treated EAE mice (a) (N¼6 mice per group).
Representative images from sham- (b) versus miPSC-NPC- (c) treated EAE mice. (d–f) Quantification of the density of CC1þ mature oligodendrocytes in
the posterior columns of the spinal cord from sham- (white bar) versus miPSC-NPC- (black bar) treated EAE mice (d) (N¼6 mice per group).
Representative images from sham- (e) and miPSC-NPC-treated EAE mouse (f). (g–i) Quantification of the number of apoptotic CC1þ mature
oligodendrocytes in the spinal cord from sham- (white bar) versus miPSC-NPC (black bar) treated EAE mice (g) (N¼6 mice per group). Representative
images from sham- (h) and miPSC-NPC-treated EAE mouse (i). Scale bars, 50mm. Arrowheads show double-positive cells. Data in panels (a,d,g) are
expressed as mean (±s.e.m.). Student’s t-test; *Po0.05; **Po0.01. (j,k) Electron micrographs representing a damaged spinal cord section from sham-
(j) and miPSC-NPC (k) treated EAE mice. Scale bar, 2 mm. (l) Quantification of the g ratios in miPSC-NPC (black) and sham- (red) treated EAE mice; data
have been generated from more than 500-myelinated axons per group (N¼ 3 mice per group) and show a significant increase of remyelinated fibres in
miPSC-NSC-transplanted mice (Student’s t-test; P¼0.04). (m,n) Quantification of the percentage of demyelinated (m) and myelinated (n) axons in
miPSC-NPC- (black) and sham- (white) treated EAE mice (N¼ 3 mice per group). Data are expressed as mean (±s.e.m.). (o) Distribution of myelinated
fibres in function of their diameter in miPSC-NPC (black bars) and sham- (white bars) treated EAE mice. (N¼ 3 mice per group). Data are expressed as
mean (±s.e.m.). (p–r) Representative images of DIG-based in situ hybridization for PLP-DM20 mRNA performed in spinal cord sections from sham-
(p) versus miPSC-NPC-treated (q) EAE mice. Scale bar, 100mm. (r) Quantification of the number of PLP-DM20þ cells in the posterior column of the spinal
cord from sham- (white bar) versus miPSC-NPC- (black bar) treated EAE mice (N¼ 3 mice per group). Data are expressed as mean (±s.e.m.).
(s,t) Western blot analysis for MBP in the spinal cord from sham- versus miPSC-NPC-treated EAE mice; blots are representative of three independent
experiments (n). Quantification of the expression levels of MBP in the spinal cord from sham- (white bars) versus miPSC-NPC- (black bars) treated EAE
mice (o). Data are expressed as mean (±s.e.m.). N¼ at least 3 mice per group. Student’s t-test and Mann–Whitney test; *Po0.05; **Po0.005.
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(Fig. 9p–s). All together these results suggest that the miPSC-
NPC-mediated trophic effect on the viability of endogenous CNS-
resident myelin-forming cells, preserves BBB permeability and
integrity and limits the continuous CNS recruitment of
encephalitogenic blood-borne inflammatory cells.
Discussion
Here we show that transplantation of miPSC-NPCs represents a
therapeutically efficacious strategy in inflammatory demyelinat-
ing disorders. The therapeutic effect was not due to a cell
replacement mechanism30–32, but to the in situ release of
neuroprotective molecules by transplanted cells. We found that
neuroinflammation occurring in EAE mice was capable to attract
miPSC-NPCs to the site of myelin damage and to instruct
such cells to secrete LIF that, in turn, promoted endogenous
myelin-forming cell survival and functionality. This mechanism,
alternative to cell replacement, renders miPSC-NPCs a suitable
candidate for cell therapy in multifocal inflammatory
demyelinating disease, such as MS. Indeed, although it was
shown that myelin-forming cells could be generated from
iPSCs3 or directly reprogrammed from somatic cells33,34, it was
not known the therapeutic potential of these cells when
transplanted into a myelin hostile inflammatory environment,
such as that characterizing MS. Given that myelin damage is
often accompanied by reactive inflammation or it is caused, as in
our experimental setting, by primary inflammation, it is
mandatory to find a population of stem/progenitor cells that is
able to exert its neuroprotective effect within an inflammatory
environment.
Although the pro survival function of LIF is not surprising
as there are several in vitro but also in vivo data suggesting that
such factor promotes OPC and mature oligodendrocyte survival
via a STAT3-mediated intracellular signalling pathway35–37,
it is surprising that the miPSC-NPC-mediated therapeutic effect
was very rapid and efficient. Our results suggest that this finding
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can be attributed to a primary neuroprotective effect of miPSC-
NPC secreted LIF leading to a secondary anti-inflammatory
effect. As a matter of fact, the neurprotective effect of LIF,
induced a less pronounced damage of myelin-forming cells and
this was sufficient to reduce the overall inflammatory burden,
which has been variably shown to be dependent on the amount of
tissue destruction38. The restraint of the inflammatory process, in
turn, provoked a reduction of the BBB leakage that eventually
inhibited CNS extravasation of encephalitogenic blood-borne
inflammatory mononuclear cells39,40. Whether or not iPSC-NPC
transplantation might favour—directly or indirectly—CNS infil-
tration of blood derived (alternatively activated) beneficial M2
monocytes/macrophages can be only envisaged at this stage;
interestingly, we observed a slight increased expression of genes
related to the M2 lineage in the spinal cord of miPSC-NPC
compared with sham-treated EAE mice.
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Data are expressed as mean (±s.e.m.). Student’s t-test; **Po0.005. (j,k) Quantification of the density of CC1þ mature oligodendrocytes (j) and of the
number of apoptotic CC1þ/Caspase3þ mature oligodendrocytes (k) in the posterior columns of the spinal cord of EAE mice 10 days after sham
(white bar), miPSC-NPC- (black bar) or miPSC-NPCs plus anti-LIF ab (dark grey bars) treatments (N¼ 3 mice per group). Data are expressed as mean
(±s.e.m.). Student’s t-test; *Po0.05.
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Figure 8 | Inflammatory CNS-infiltrate cellular characteristics in EAE mice transplanted with miPSC-NPCs. (a–e) Flow cytometry of CNS-infiltrating
blood-borne inflammatory cells in sham versus miPSC-NPC-treated EAE mice at 30 dpi (N¼4 mice per group). CNS-infiltrating leukocytes are
gated as CD45hiCD11b cells, T-cell subpopulations as CD4þ (a) and CD8þ (b), B cells as CD45hi CD11b B220þ (c), macrophages (MF) as CD45hi
CD11bþ CD11c (d), and dendritic cells (mDC) as CD45hi CD11bþ CD11cþ (e). Percentages have been calculated on the total CD45-gated cells (± s.d.).
(f–m) Representative plots of all CNS-infiltrating inflammatory cells. Sham-treated EAE mice are represented in the upper panels (f,h,j,l), whereas
miSPC-NPC-treated EAE mice in the lower panels (g,i,k,m). (n) Quantification of encephalitogenic Th1 and Th17 cells derived from sham versus miPSC-
NPC-treated EAE mice at 30 dpi. Percentages have been calculated on the total CD45hiCD4þ gated cells (±s.d.). (o) Representative plots of CNS-
infiltrating Th1 and Th17 cells population, identified based on their production of IFNg and IL-17A, respectively, on sham-treated (left) and miPSC-NPC
(right)-treated EAE mice. (p–t) Real-time PCR-based expression analysis of M2-type monocytes/macrophages-related genes in the spinal cord tissue
from miPSC-NPC- (black bars) and sham-treated (white bars) EAE mice (N¼ 5 mice per group). Results are expressed as fold increase over basal
expression level in sham-treated mice (mean±s.e.m.).
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(vWF) in sham- (l) and miPSC-NPC- (m) treated EAE mice. Scale bar,50mm. (n–q) Quantification of IgG extravasation in the spinal cord of miPSC-NPC (black
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histochemistry for IgG extravasation in sham- (r) versus miPSC-NPC-treated (s) EAE mice. Broken red lines indicate the posterior columns. Scale bar, 200mm.
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Finally, we cannot exclude that the neuroprotective effect
exerted by miPSC-NPCs could be amplified by other cell
types known to secrete LIF (that is, astrocytes). Moreover, other
factors may have influenced the LIF-mediated effect on
oligodendrocytes, as a similar effect was recently observed for
mesenchimal stem cell transplantation via hepatocyte growth
factor secretion41.
In conclusion, although proposing a novel mechanism of action
our results further expand the therapeutic potential of iPSC-derived
NPCs and suggest that preservation of myelin-forming cells integrity
might represent a valid anti-inflammatory strategy to promote tissue
repair in immune-mediated demyelinating disorders.
Methods
Lentiviral Vector (LV) production. A LV expressing the Oct4, Sox2 and Klf4 genes
from a single cistron (named reprogramming LV—rep.LV) and a LV expressing
ubiquitously eGFP (named LV.eGFP) were used in this study. LVs were prepared
as previously described42. Briefly, 293T cells were co-transfected by calcium
phosphate precipitation with the following four plasmids: the transfer vector
plasmid (32mg), being either the transfer vector containing the expression cassette
for the reprogramming genes or the transfer vector expressing eGFP; the pMD.Lg/
pRRE packaging plasmid (12.5mg); the pMD2.VSV-G envelope-encoding plasmid
(9mg); (iv) pCMV-Rev (6.25mg). Viral vectors were concentrated by ultra-
centrifugation and transduced cells were analysed by FACS (FACSCalibur, Becton
Dickinson Immunocytometry Systems).
Fibroblast culture and miPSC generation. MEFs were isolated from E14.5
C57BL/6 Sox2bgeo/bgeo knock-in mice embryos12. These mice contain a bgeo
cassette that encodes for b-galactosidase activity (lacZ) as well as G418 resistance.
Fibroblasts were cultured in Dulbecco’s modified Eagle’s medium (DMEM) high
glucose (Euroclone), 15% fetal bovine serum (FBS; Euroclone), 2mM L-glutamine
(Euroclone), and 1% penicillin/streptomycin (Invitrogen). For iPSC generation, 105
fibroblasts were infected with the rep.LV in DMEM 10% FBS and 4 mgml 1 of
polybrene. After 1 week, the transduced fibroblasts were plated on a feeder layer of
Mitomycin C (Sigma-Aldrich) treated MEFs (1.2 106 cells per 10 cm dish) in
DMEM supplemented with 15% FBS, 2mM L-glutamine, 0.1mM nonessential
amino acids, 1mM sodium pyruvate, 0.1mM b-mercaptoethanol, 5mgml 1
penicillin, 100mgml 1 streptomycin and 103Uml 1 LIF (Chemicon
International). Medium was changed every day and colonies started to appear
20 days later. At around day 40, colonies were transferred to a new feeder layer
Neomicin resistant and pluripotent colonies were selected thanks to their resistance
to G418 treatment (Neomicin analogue). Subsequently, miPSCs clones were split
by Trypsin treatment every 2 days at a 1 to 6 dilution. Pluripotency of miPSCs have
been assessed by RT–PCR using a set of primers previously described13:
Oct4 endo TCTTTCCACCAGGCCCCCGGCTC TGCGGGCGGACATG
GGGAGATCC (224 bp); Sox2 endo TAGAGCTAGACTCCGGGCGATGA
TTGCCTTAAACAAGACCACGAAA (297 bp); Klf4 endo GCGAACTCACACA
GGCGAGAAACC TCGCTTCCTCTTCCTCCGACACA (711 bp).
AP staining. Direct AP activity was analysed using the NBT/BCIP (AP) blue
substrate (Roche), according to the manufacturer’s guidelines. LacZ staining was
performed on cultured cells after fixation for 3min at 4 C with 4% paraf-
ormaldehyde (PFA) and then incubated for 12 h at 37 C in X-Gal reaction buffer
(PBS, 35mM potassium ferrocyanide, 35mM potassium ferricyanide, 2mM
MgCl2, 0.02% nonidet P-40 (NP-40), 0.01% Na deoxycholate) containing
1mgml 1 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal;
Sigma-Aldrich).
Embryoid body differentiation. miPSCs were dissociated by Trypsin (Invitrogen)
incubation for 20min at 37 C; EBs were generated by culturing the cells in sus-
pension on bacterial dish (Sterlin) at 105 cellsml 1 in mES medium without LIF.
After 3 days, EBs were plated on 0.1% gelatin (Sigma-Aldrich) coated
tissue culture dishes and cells were analysed 4 days after.
Chimera generation. After injection of 8–10 Sox2bGeo miPSCs in each E3.5
blastocyst isolated from C57Bl/6 mice, blastocysts were transferred into E2.5
pseudo-pregnant CD1 females, and chimeras were analysed at embryonic
day 13–14 by GFP fluorescence.
Teratoma formation. SCID beige mice were anaesthetized with 140ml of anaes-
thetic solution containing 12.5% ketamine and 6.25% xylazine in 0.9% saline
solution before starting surgery. Testes were exposed and 1 106 miPSCs resus-
pended in 10ml of PBS were injected within the right testis. The successful rate of
teratoma generation was of 100% and after 6 weeks mice were killed. Tumours
were removed and processed for light microscopy. Paraffin-embedded tissue sec-
tions were stained for hematoxylin and eosin.
Derivation and culture of miPSC-NPCs. miPSC-NPCs were obtained from
Sox2bgeo miPSCs following the published protocol13. miPSC-NPCs were cultured
in adhesion in NPC proliferation medium: Euromed-N medium (Euroclone), N2
supplement (Invitrogen), 20 ngml 1 EGF (Peprotech Inc.) and 20 ngml 1 FGF-2
(Peprotech Inc.). For routine passaging, miPSC-NPCs were dissociated to single-
cell suspension with Acutase (Sigma) and split 1:4 or 1:5 every 2–3 days.
Differentiation of miPSC-NPCs. miPSC-NPCs were differentiated into astrocytes,
neurons and oligodendrocytes as previously described13,15,16. Briefly, astrocytes
were obtained by adding 5% of FBS to the medium culture. For neural
differentiation, miPSC-NPCs were exposed to B27, then plated on laminin-coated
glass coverslips in the presence of decreasing concentrations of FGF-2 while
gradually adding brain-derived neurotrophic factor up to 30 ngml 1 in
10–15 days. To obtain oligodendrocytes, miPSC-NPCs were plated on glass
coverslips pre-treated with polyornithine and laminin. Oligodendrocyte differ-
entiation required an intermediate glial precursor stage, supported by the platelet-
derived growth factor (PDGF)a and the mitogen forskolin, followed by growth
factor withdrawal and addition of triiodothyronine (T3) and ascorbic acid (AA)
for 1 week to promote terminal differentiation into the oligodendrocyte lineage.
EAE induction. Chronic-relapsing EAE was induced in 6–8 weeks C57Bl/6 female
mice (Charls River) by subcutaneous immunization with MOG35–55 peptide
(200 mg per mouse) in incomplete Freund’s adjuvant containing 8mgml 1
Mycobacterium tuberculosis (strain H37Ra; Difco). Mice were i.v. injected with
500 ng of pertussis toxin (Sigma) the day of the immunization and 2 days later.
Body weight and clinical score (0¼ healthy; 1¼ limp tail; 2¼ ataxia and/or
paresis of hindlimbs; 3¼ paralysis of hindlimbs and/or paresis of forelimbs;
4¼ tetraparalysis; 5¼ death) was recorded daily6.
All procedures involving animals were performed according to the guidelines of
the Animal Ethical Committee of our Institute (IACUC).
miPSC-NPC transplantation. Six to eight weeks C57Bl/6 female mice (Charls
River) were anaesthetized with 12.5% ketamine and 6.25% xylazine in 0.9% saline
solution. miPSC-NPCs, murine fibroblasts and murine astrocytes (1 106 cells per
mouse diluted in 10 ml) were transplanted by stereotaxic injection into cisterna
magna of EAE mice at the peak of the disease (4 days after disease onset). Age- and
sex-matched sham (PBS)-treated EAE mice were sued as controls. MEFs were
obtained by C57Bl/6 mouse pups as described above, while mouse primary
astrocytes were prepared from newborn mice following published procedures43.
Briefly, forebrains were collected from newborn C57Bl/6 mouse pups and carefully
freed of meninges, chopped into 0.25-mm sections and dissociated by a mild
trypsinization procedure and gentle mechanical disruption with a Pasteur pipette.
The cells were seeded into poly-L-lysine (10mgml 1)-coated 175-cm2 flasks at the
density of 4 104 cells cm 2 and grown at 37 C in a 92% air–8% CO2 humidified
atmosphere in DMEM (Invitrogen) containing 0.45-mm filtered, 10% FBS (Invi-
trogen), 2mM glutamine (BioWhittaker, Verviers, Belgium), penicillin
(100Uml 1) and streptomycin (100 mgml 1). The medium was replaced after
24 h and then every 3 days. After about 10 days in vitro, primary cultures were
vigorously shaken to detach microglia and oligodendrocytes growing on top of the
astrocytic layer. The remaining adherent cells were detached with trypsin (0.25%)/
EDTA, resuspended in fresh medium and reseeded on poly-L-lysine-coated plastic
surfaces. Purity of mouse astrocyte cultures was checked by GFAP staining and was
495%. At the time of killing—which occurred at different time points after
immunization (30, 40 and 80 dpi)—at least 10 mice per group were anaesthetized
and transcardially perfused with saline solution followed by 4% PFA. Brains, spinal
cords and peripheral organs (heart, lungs, liver, spleen, gut and kidney) were
removed and processed for light and electron microscopy.
LIF neutralization in EAE mice. Subcutaneous osmotic minipumps (ALZET,
model 1007) were implanted in EAE mice after sham or miPSC-NPC treatment.
Two microgram per day of LIF neutralizing antibody (R&D) were dissolved in
PBS and administered for 7 days intracerebroventricularly to EAE mice using a
brain catheter (Brain Infusion Kit 3, ALZET) connected to the subcutaneously
implanted osmotic minipump. Stereotaxic apparatus was used to determine the
exact location of the brain catheter inside the lateral ventricle (from bregma,
0.3mm anterior, 0.8 lateral).
Neuropathological analysis. Paraffin-embedded tissue sections were stained for
hematoxylin and eosin, Luxol fast blue and Bielshowsky silver impregnation to
detect inflammatory infiltrates, demyelination and axonal loss, respectively. The
number of perivascular inflammatory infiltrates was calculated as the mean
number of inflammatory infiltrates per spinal cord section. Six animals per group
were analysed. For analysis of demyelination and axonal damage, paraffin-
embedded, adjacent serial transverse spinal cord sections (5 mm) were stained with
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Luxol fast blue/periodic-acid Schiff staining and Bielschowsky silver impregnation.
Tissue damage was marked with ImageJ and expressed as the percentage of damage
area on the entire spinal cord section. At least 5 animals per group (miPSC-NPCs
and Sham) were analysed and 12 to 20 different rostro-caudal sections were
marked per animal. Statistical significance was assessed by unpaired Student’s
t-test.
Immunofluorescence and immunohistochemistry. Cells in culture and tissues
(20 mm) were fixed with 4% PFA in phosphate buffer solution (PBS) pH 7.2 and
tissues were cryoprotected for at least 24 h in 30% Sucrose (Sigma) in PBS at
þ 4 C. Coronal brain and spinal cord sections (20 mm) and fixed cells were
incubated with blocking solution (PBS 1x, FBS 10%, BSA 1mgml 1 and Triton
0.1%) for 1 h and then primary antibodies were applied in the same solution over
night at þ 4 C. The following primary antibodies were used: mouse a-OCT4
(1:50, Santa Cruz Biotechnology); rabbit a-Nanog (1:200, Millipore); mouse
a-SSEA3 (1:150, Millipore); Foxa2; aSMA; mouse a-Vimentin (1:200, Abcam);
rabbit a-Mash1 (1:200, Chemicon); GLAST; rabbit a-Sox2 (1:100, Millipore);
a-Ki67 (1:1,000, Novocastra); rabbit a-TuJ1 (1:1,000, Covance); rabbit a-Olig2
(1:200, Chemicon); mouse a-Olig2 (1:300, Chemicon); mouse a-GFAP
(1:1,000, Chemicon); rabbit a-GFAP (1:1,500, Dako); mouse a-O4 (1:100, Milli-
pore); rabbit a-NG2 (1:200, Santa Cruz); mouse a-Nestin (1:100, BD Pharmagen);
chicken a-GFP (1:300, Abcam); rabbit a-pSTAT3 (1:200, Cell Signalling); rabbit a-
STAT3 (1:200, Cell Signalling); rat a-MBP (1:200, Chemicon); goat a-LIF (1:50,
R&D); mouse a-APC (1:100, Calbiochem); mouse a-ZO-1 (1:150, ); rabbit a-von
Willebrand Factor (1:1000, Abcam); rat a-CD45 (1:100, BD Pharmagen); rabbit
a-caspase3 clived (1:200, Cell Signalling). Appropriate fluorophore-conjugated
secondary antibodies (Alexa Fluor 488, 546, 405 and 633, Molecular Probes) or
alternatively the chromogen DAB (Vector Laboratories) were used for detection
accordingly manufacturer’s instructions. Omission of the primary antibodies
showed no specific staining. Nuclei were stained with 40,6-diamidino-2-pheny-
lindole (DAPI, Roche). Immunopositive cells within lesions were counted once
the extent of the demyelination had been established with Luxol fast blue staining
on adjacent sections. Microscopy was performed using Light (Olympus, BX51
equipped with  4 and  20 objectives) and confocal (Leica, SP5 equipped with
 20 and  40 objectives) and images were analysed by using Leica LCS lite and
Adobe Photoshop CS software (Adobe Systems Incorporated, CA 95110, USA).
in situ hybridization. Radioactive and DIG in situ hybridization were performed
as follows44. Briefly, radioactive in situ hybridization was performed on 20 mm-
thick spinal cord sections post-fixed 15min in 4% PFA, washed three times in PBS
and incubated in 0.5mgml 1 of Proteinase K (Roche) in 100mM Tris-HCl
(pH 8), 50mM EDTA for 10min at 30 C. After a second 15min fixation was done
in 4% PFA, slices were then washed three times in PBS, once in H2O and then
incubated in triethanolamine (Merk) 0.1M (pH 8) for 5min. Four hundred
microlitre of acetic anhydride (Sigma) was added twice for 5min. Finally, sections
were rinsed in H2O for 2min and air-dried. Hybridization was performed
overnight at 60 C with a-UTP-P33 (GE) LIF riboprobe at a concentration ranging
from 106 to 107 counts per minute (c.p.m.). The day after, sections were rinsed in
SSC 5X for 5min then washed in formamide 50% (Sigma)-SSC 2X for 30min at
60 C. Slides were then incubated in ribonuclease-A (Roche) 20mgml 1 in 0.5M
NaCl, 10mM Tris-HCl (pH 8), 5mM EDTA 30min at 37 C, then washed in
formamide 50% SSC 2X for 30min at 60 C and rinsed two times in SSC 2X.
Finally, slides were dried using ethanol series. Lm1 (GE Healthcare Life Sciences,
Milan, Italy) emulsion was applied in dark room, according manufacturer’s
instructions. After 1 week, sections were developed in dark room, counterstained
with DAPI and mounted with DPX (BDH) mounting solution.
DIG in situ hybridization was performed as described for radioactive one. In
details, PLP-DM20 riboprobe was synthesized using DIG RNA Labeling Mix
(Roche). Hybridization was performed overnight at 60 C with Digriboprobes.
After last SSC 2X wash, slices were incubated in Tris-HCl 2M, NaCl 5M for 1 h at
room temperature. Primary antibody a-Dig-POD (a-Dig conjugated with horse-
radish peroxidase; 1:2,000, Roche) was added and incubated overnight at 4 C.
Sections were then washed with 0.1M Tris-HCl pH¼ 9.5, 0, 1M NaCl, 50mM
MgCl2 and subjected to BCIP (5-bromo-4-chloro-3-indolyl-phosphate)/NBT (nitro
blue tetrazolium) for the colorimetric detection.
PLP-DM20 riboprobe was kindly provided by Robin Franklin (Cambridge, UK)
and LIF riboprobe was PCR generated based on NCBI Reference Sequence
NM_001039537. Microphotographs of sections were digitalized in dark field light
microscopy (Olympus BX51, and  4 objective) by using a CCD camera (Leica).
Images were analysed by using Adobe Photoshop CS. To confirm the specificity of
the different RNA probes, sense strand RNA probes (showing no signal) were used
as negative controls.
Electron microscopy. Mice were perfused as described above. Spinal cord tissue
was removed and fixed with 2% (vol/vol) glutaraldehyde in 0.12M phosphate
buffer, post-fixed with 1% (wt/vol) osmium tetroxide and embedded in Epon
(Fluka). Semithin (1 mm thick) and ultrathin (70–80 nm thick) sections were cut
from the spinal cord. Semithin sections were stained with toluidine blue. For
electron microscopy, ultrathin sections were stained with uranyl acetate and lead
citrate and examined by electron microscopy (Leo 912 Omega) using a  100
objective45. The percentage and the number of myelinated/demyelinated axons and
G ratio measurements were performed on digitized non overlapping electron
micrographs images. G ratios were determined by dividing the mean diameter of an
axon without myelin by the mean diameter of the same axon with myelin. To
determine the size distribution of myelinated fibres in the spinal cord, diameters of
all fibres in at least 10 randomly chosen representative images were measured and
binned based on their width. The number of myelinated and nonmyelinated axons
were counted in at least ten randomly chosen representative images. All
measurements were acquired on  100 semithin section images.
Immunoblotting. Spinal cord tissue was collected from at least three saline per-
fused EAE mice per group and homogenized in a lysis buffer containing 2% SDS,
95mM NaCl, 10mM EDTA, 1mM PMSF, 10mgml 1 aprotinin, 20mM leupeptin,
1mM orthovanadate and 2.5mM sodium pyrophosphate in 25mM Tris buffer (pH
7.4). Protein concentrations were determined by the BCA method (Pierce)46. Ten
to 20 mg of protein for samples were fractionated by SDS–PAGE and blotted onto
nitrocellulose (Protran Biosciences). After blocking in 4% milk in TBST (0.1%
Triton X-100 in TBS), appropriate regions were incubated with specific primary
antibody prepared in 5% BSA, 0.05% sodium azide in TBST and secondary anti-
bodies and developed with the ECL western blotting Detection Reagent (GE
Healthcare). Semi-quantitative western blot analysis was performed using ImageJ
software. Raw data are shown in Supplementary Fig. S4. Antibodies: mouse
monoclonal a-MBP (SMI-94, SMI-99); rabbit a-phospho-STAT3 (1:200, Cell
Signalling); rabbit a-STAT3 (1:200, Cell Signalling).
OPC culture. In our in vitro studies we used rat oligodendrocyte precursors fol-
lowing the myelinating oligodendrocyte coculture system developed by Chan et al.47
This is a well established and used system that allows the preparation of a significant
amount of pure OPCs. We purposely used rat oligodendrocytes in order to obtain
enough pure cells for performing all the in vitro experiments. Thus, to avoid
possible effects due to species’ differences, we have tested the effects of LIF and
conditioned media also on rat OPCs prepared by differential immunopanning.
Primary OPCs from P1 Sprague–Dawley rat cortices were grown over an astrocyte
monolayer in DMEM, 10% FBS (Invitrogen). After 10 days, OPCs were separated by
orbital shaking and immunopanned using anti Ran-2 and A2B5 (refs 47,48). Fifty
thousand A2B5þ OPCs were plated on poly-lysin coated glass coverslips and kept
in DMEM containing 10% FBS. The following day, medium was changed to SATO
medium supplemented with proliferating (10 ngml 1 FGF and 10 ngml 1
PDGFa) or differentiating (30ngml 1 T3) growth factors or to conditioned SATO
medium. Conditioned medium was obtained by the culture of 1 106 miPSC-NPCs
in 5ml of SATO for 24 h with or without inflammatory cytokines (10 ngml 1 IFNg
and 15 ngml 1 TNFa). For LIF neutralization, supernatant of miPSC-NPCs
cultured with or without inflammatory cytokines was harvested at 24 h from
miPSC-NPC cultures and supplemented with LIF neutralizing antibody (R&D)
(0.5mgml 1). Recombinant LIF (rLIF) (1 ngml 1) was added to SATO medium as
positive control. At least four coverslips were subjected to each culture condition
and three biological replicate were performed. In this culturing condition,
differentiation of OPCs was quantified by counting the number of MBPþ (that
is, mature oligodendrocytes), O4þ (that is, OPCs and oligodendrocytes), and
O4þ /Ki67þ (that is, OPCs) cells in at least 10 fields per the coverslip.
RNA extraction and RT–PCR. Total RNA was extracted from the spinal cord of
minimum five mice per group and from cells using Trizol reagent (Invitrogen) and
residual DNA was removed by treatment with 1U DNase per 1mg RNA (RQ1
RNase-free DNase, Promega) at 37 C for 30min according to manufacturer’s
procedures. cDNA synthesis was performed by using ThermoScriptTM RT–PCR
System (Invitrogen) and Random Hexamer (Invitrogen). mRNA levels were
measured by real-time RT–PCR (Applied Biosystem, Invitrogen). The 2 DDCT
method was used to calculate relative changes in gene expression49. The following
Applied Biosystem (Invitrogen) probes were used: LIF (Mm00434761_m1), FGF-2
(Mm00433287_m1), PDGF (Mm00833533_m1), CNTF (Mm00446373_m1),
TGFb (Mm03024053_m1), Noggin (Mm00476456_s1), BMP4
(Mm00432087_m1), Chaderin-5 (Cdh5) (Mm00486938_m1), ICAM
(Mm00476227_m1), VCAM1 (Mm00449197_m1), PECAM1 (Mm01242584_m1),
ITGAL (Mm00801807_m1), ZO-1 (Mm01320637_m1), Pten (Mm1212532_m1),
IL4ra (Mm01275139_m1), YM-1 (Mm00657889_m1), CD206 (Mm00485148_m1),
and Arg1 (Mm00475988_m1).
Isolation of CNS-infiltrating mononuclear cells. Ten days after the treatment,
EAE mice were intracardially perfused with cold HBSS and spinal cords and
hindbrains were collected. Tissues were homogenized with neural tissue dissocia-
tion kit according to the manufacturer’s procedures (Miltenyi Biotech). CNS-
infiltrating mononuclear cells were isolated from discontinuous 30%:70% Percoll
gradient50. Briefly, the homogenate was resuspended in 30% Percoll (Pharmacia,
Piscataway, NJ), and underlaid with 70% Percoll. The gradients were centrifuged at
2,400 g at 24 C for 20min. CNS mononuclear cells were collected from the Percoll
interface, washed and resuspended in FACS buffer (phenol red negative Hank’s
BSS with 10% FBS) for further analysis.
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Flow-activated cytometric analysis. For surface staining, CNS-infiltrating cells
isolated form EAE mice or miPSC-NPCs were incubated with 5% fetal calf serum,
2% rat serum and 2.5 mgml 1 rat anti-mouse Fc III/II receptor (CD16/CD32)
blocking antibodies (BD Pharmingen) for 10min at 4 C and then stained for
30min at 4 C with the following directly conjugated monoclonal primary anti-
bodies specific for mouse antigens: CD4 (RM4-5), CD11b (M1/70), CD11c (N418),
CD45.2 (104), CD8 (Ly-2), CD45R/B220 (RA3-6B2), CD44 (IM/7) (BD Phar-
mingen), VLA-4 (PS/2; Abcam), CXCR4 (2B11; eBioscience). As negative control,
we used florescence mix minus one colour for multiple staining and the corre-
sponding isotype control for single staining. For intracellular cytokine staining,
cells were stimulated for 6 h with phorbol 12-myristate 13-acetate (50 ngml 1)
and ionomycin (500 ngml 1) in the presence of GolgiPlug (BD Pharmingen).
Then, cells were stained for surface molecules, fixed and made permeable with a
Cytofix/Cytoperm Plus kit (BD Bioscience) and stained with the following anti-
bodies: IL-17A (TC11-18H10) and IFN-g (XMG1.2) (all from BD Pharmingen).
The cells were washed and analysed. Data were acquired with a Canto II flow
cytometer (Becton Dickinson) and analyses were performed with DIVA or FCS
Express V3 software.
Microarray analysis. Three mice per group (naive, miPSC-NPC-treated or sham-
treated), at 40 dpi, were anaesthetized and transcardially perfused with RNase-free
0.9% saline containing 10Uml 1 of heparin at 40 dpi. CNS was collected, and
brain and spinal cord of each animal were separately homogenized in 1ml of
QIAzol Lysis Reagent (Qiagen, Valencia, CA, USA, #79306) using a rotor-stator
homogenizer. RNA was extracted according to manufacturer instructions and their
concentration was determined spectrophotometrically by A260 (Nanodrop-ND
1000, Nanodrop, Wilmington, DE, USA). cRNA amplification was performed
using the Illumina TotalPrep RNA Amplification Kit (Ambion) and 1.5 mg of
biotin-labelled cRNA of each sample was hybridized on Illumina MouseWG-6 v2
expression bead chip (Illumina). The array contained 45281 probes representing
transcripts contained in the NCBI-Refseq, Riken, and Meebo databases. The raw
data were background subtracted and cubic spine normalized using Illumina
GenomeStudio software. Detection P-values reported by the GenomeStudio were
used to estimate the amount of detected probes51, and a threshold of detection P-
valueo0.05 was applied for filtering. No outlier samples were found in principal
component analysis and hierarchical sample clustering. Differential gene
expression analysis were performed in the R-bioconductor platform and the
empirical Bayes test was used as implemented in the LIMMA package52. DEG
passed P-valueo0.01 and ±1.7 fold change thresholds and were used for
bioinformatical functional annotation. Pathway and Gene Onotology enrichment
analyses were performed using the Genecodis tool53, with the enrichment criteria
of at least three genes in one category and P-valueo0.05, computed from w2-test
followed by Benjamini–Hochberg’s correction.
Statistical analysis. Statistical evaluations of RT–PCR data, immunoblot data,
FACS data, EAE score and immunohistochemical analyses results were expressed
as mean±s.e.m. Results were analysed using the unpaired Student’s t-test and
two-way ANOVA for clinical score analysis. Mann–Whitney test was used when
non parametric data have been compared and analysed. Analyses were performed
using the Prism V5.0a software (Graph-Pad, San Diego, CA, USA). Statistical
significance was accepted when *Po0.05, **Po0.01, ***Po0.001.
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